FSD Pharma Inc.
HUGE · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $2,366,967 | $1,985,035 | $2,316,867 | $1,221,258 |
| - Cash | $2,757 | $16,980 | $35,260 | $17,525 |
| + Debt | $339 | $516 | $556 | $511 |
| Enterprise Value | $2,364,549 | $1,968,570 | $2,282,164 | $1,204,243 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$2,552 | -$4,358 | -$4,010 | -$4,107 |
| % Margin | – | – | – | – |
| EBITDA | -$16,012 | -$22,120 | -$29,823 | -$24,316 |
| % Margin | – | – | – | – |
| Net Income | -$18,565 | -$23,322 | -$35,406 | -$32,719 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.47 | -0.6 | -1.01 | -2.72 |
| % Growth | 21.7% | 40.6% | 62.9% | – |
| Operating Cash Flow | -$11,026 | -$28,333 | -$20,746 | -$19,130 |
| Capital Expenditures | -$32 | -$364 | -$500 | $0 |
| Free Cash Flow | -$10,827 | -$28,697 | -$21,246 | -$19,130 |